Patent · US Active

Compositions and methods related to xCT peptides

US10588953B2 · kind B2 · utility

0Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2016
Grant dateMar 17, 2020
Priority date—
Expiry dateDec 18, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2795/00041
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.